Royce & Associates’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-20,000
| Closed | -$1.47M | – | 1202 |
|
|
2019
Q1 | $1.47M | Sell |
20,000
-11,100
| -36% | -$814K | 0.01% | 809 |
|
|
2018
Q4 | $1.32M | Hold |
31,100
| – | – | 0.01% | 813 |
|
|
2018
Q3 | $1.47M | Sell |
31,100
-20,000
| -39% | -$942K | 0.01% | 872 |
|
|
2018
Q2 | $2.52M | Sell |
51,100
-10,000
| -16% | -$493K | 0.02% | 776 |
|
|
2018
Q1 | $1.88M | Sell |
61,100
-60,000
| -50% | -$1.84M | 0.01% | 866 |
|
|
2017
Q4 | $2.21M | Sell |
121,100
-130,000
| -52% | -$2.37M | 0.01% | 823 |
|
|
2017
Q3 | $2.94M | Hold |
251,100
| – | – | 0.02% | 731 |
|
|
2017
Q2 | $917K | Buy |
251,100
+118,063
| +89% | +$431K | 0.01% | 985 |
|
|
2017
Q1 | $692K | Buy |
+133,037
| New | +$692K | ﹤0.01% | 1020 |
|